Furthermore, estrogen was also suggested to be involved in reduction of secondary bile acid production, circulating IGF-I, and inhibiting cell proliferation of colorectal tumors by binding to the estrogen receptor. This evidence concerns the gene IGF1 and colorectal neoplasm.